NovaBay Pharma (NBY) Misses Q1 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
NovaBay Pharmaceuticals Reports 2016 First Quarter Financial Results
May 12, 2016 4:11 PM EDTCloses the first tranche of an $11.8 million private placement Affirms outlook to reach positive cash flow from operations by the end of 2016 First quarter 2016 sales reached $1.7 million and $2.3 million on a pro forma non-GAAP basis Recent highlights feature clinical validation that Avenova® reduces the bacteria that can cause blepharitis and the launch of a new marketing strategy Conference call begins today at 4:30 p.m. Eastern time
EMERYVILLE, Calif.--(BUSINESS WIRE)--... More



